Immediate Impact
2 from Science/Nature 57 standout
Citing Papers
Multiple sclerosis
2023 Standout
Atogepant for the preventive treatment of chronic migraine (PROGRESS): a randomised, double-blind, placebo-controlled, phase 3 trial
2023 Standout
Works of Kory Schuh being referenced
Positive response to galcanezumab following treatment failure to onabotulinumtoxinA in patients with migraine: post hoc analyses of three randomized double‐blind studies
2019
Neurobiology of Alzheimer’s Disease: Integrated Molecular, Physiological, Anatomical, Biomarker, and Cognitive Dimensions
2015
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Kory Schuh | 1258 | 428 | 654 | 57 | 2.4k | |
| Himanshu P. Upadhyaya | 1217 | 658 | 657 | 76 | 2.9k | |
| Vanessa Raymont | 1114 | 445 | 868 | 96 | 3.6k | |
| Chiadi U. Onyike | 1450 | 662 | 664 | 78 | 3.5k | |
| Allen E. Thornton | 1069 | 303 | 738 | 93 | 3.1k | |
| Jared Tinklenberg | 1252 | 537 | 1498 | 104 | 4.1k | |
| Cynthia A. Munro | 1610 | 606 | 752 | 87 | 4.1k | |
| David Bachman | 1256 | 966 | 686 | 67 | 3.3k | |
| Paul J. Massman | 1742 | 914 | 1065 | 72 | 3.6k | |
| David Ames | 1517 | 1017 | 542 | 93 | 3.3k | |
| Peter W. Schofield | 927 | 643 | 411 | 91 | 3.2k |
All Works
Login with ORCID to disown or claim papers
Loading papers...